<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>tumor heterogeneity &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-heterogeneity/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 05:58:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>tumor heterogeneity &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Decoding Cancer: A Guide to Transcriptomic Deconvolution</title>
		<link>https://bioengineer.org/decoding-cancer-a-guide-to-transcriptomic-deconvolution/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 05:57:41 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer immune microenvironment]]></category>
		<category><![CDATA[computational biology]]></category>
		<category><![CDATA[computational oncology]]></category>
		<category><![CDATA[immune microenvironment]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket (virgülle ayrılmış): **Transcriptomic Deconvolution]]></category>
		<category><![CDATA[personalized cancer therapy]]></category>
		<category><![CDATA[Personalized Medicine** **Kısa Açıklama:** 1. **Transcriptomic Deconvolution:** Makalenin ana konusu ve temel tekniği. 2. **Tumor Heterogeneity:** Makalenin çözmeye çalışt]]></category>
		<category><![CDATA[Transcriptomic Deconvolution]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/decoding-cancer-a-guide-to-transcriptomic-deconvolution/</guid>

					<description><![CDATA[In the complex landscape of cancer research, the inherent heterogeneity of tumor tissues presents both challenges and opportunities for understanding the intricacies of tumor biology. Each tumor consists of a broader mixture of tumor cells, stromal components, and diverse immune cells, making it critical for researchers to unravel the particular contributions of various cell types [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318755</post-id>	</item>
		<item>
		<title>T-Cell Receptor Therapy in Ovarian Cancer: Challenges Ahead</title>
		<link>https://bioengineer.org/t-cell-receptor-therapy-in-ovarian-cancer-challenges-ahead/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 01 Dec 2025 02:32:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[Cancer Research Advancements** **Kısa Açıklama:** 1. **T-Cell Receptor Therapy:** Makalenin ana konusu. 2. **Ovarian Cancer:** Tedavinin hedeflediği spesifik kanser türü]]></category>
		<category><![CDATA[İşte 5 uygun etiket (virgülle ayrılmış olarak): **T-Cell Receptor Therapy]]></category>
		<category><![CDATA[Ovarian cancer]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/t-cell-receptor-therapy-in-ovarian-cancer-challenges-ahead/</guid>

					<description><![CDATA[Researchers around the globe are striving to harness the power of the immune system to combat various forms of cancer, and the latest advancements in T-cell receptor (TCR) therapy have opened up new horizons in the treatment of ovarian cancer. This emerging therapeutic strategy is founded on the potential of T-lymphocytes to recognize and eliminate [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303751</post-id>	</item>
		<item>
		<title>SPP1 Crucial for Pancreatic Cancer Cell Fate</title>
		<link>https://bioengineer.org/spp1-crucial-for-pancreatic-cancer-cell-fate/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 24 Sep 2025 16:42:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[BMP2 GREM1 axis]]></category>
		<category><![CDATA[mesenchymal cell fate]]></category>
		<category><![CDATA[paracrine signaling]]></category>
		<category><![CDATA[SPP1 pancreatic cancer]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/spp1-crucial-for-pancreatic-cancer-cell-fate/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature, researchers have unraveled a crucial cellular dialogue that sustains pancreatic ductal adenocarcinoma (PDAC), one of the deadliest forms of cancer due to its notorious resistance to therapy and aggressive progression. The investigation reveals an intricate paracrine network between epithelial and mesenchymal cancer cell populations, mediated by three diffusible [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">271819</post-id>	</item>
		<item>
		<title>Single-Cell Insights Unveil Pituitary Tumor Progression</title>
		<link>https://bioengineer.org/single-cell-insights-unveil-pituitary-tumor-progression/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 30 May 2025 01:44:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[immune microenvironment remodeling]]></category>
		<category><![CDATA[pituitary neuroendocrine tumors]]></category>
		<category><![CDATA[single-cell transcriptomics]]></category>
		<category><![CDATA[spatial transcriptomics technology]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/single-cell-insights-unveil-pituitary-tumor-progression/</guid>

					<description><![CDATA[In a groundbreaking study poised to transform our understanding of pituitary neuroendocrine tumors (PitNETs), researchers have deployed cutting-edge single-cell and spatial transcriptomic technologies to unravel the complex cellular heterogeneity and immune landscape that drive tumor progression. Published in Nature Communications, the research led by Su, Ye, Liu, and colleagues provides an unprecedented molecular atlas of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">247335</post-id>	</item>
		<item>
		<title>Unveiling the Hidden DNA Circles Driving the Aggressiveness of Pancreatic Cancer</title>
		<link>https://bioengineer.org/unveiling-the-hidden-dna-circles-driving-the-aggressiveness-of-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 12 Mar 2025 16:23:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[extrachromosomal DNA]]></category>
		<category><![CDATA[MYC oncogene]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[therapy resistance]]></category>
		<category><![CDATA[tumor heterogeneity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unveiling-the-hidden-dna-circles-driving-the-aggressiveness-of-pancreatic-cancer/</guid>

					<description><![CDATA[Researchers at the University of Verona, in collaboration with the University of Glasgow and the Botton-Champalimaud Pancreatic Cancer Centre, are shedding light on an astonishing factor in pancreatic cancer that may revolutionize how we understand and treat this lethal disease. The study, which has recently garnered attention, highlights the significant role of extrachromosomal DNA (ecDNA) [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">238209</post-id>	</item>
	</channel>
</rss>
